Goldman Sachs
MJN

Goldman Sachs’s Mead Johnson Nutrition Company MJN Stock Holding History

Goldman Sachs’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-30,000
Closed -$2.12M – 7188
2016
Q4 		$2.12M Buy
+30,000
New +$2.24M ﹤0.01% 3806
2016
Q2 		– Sell
-85,500
Closed -$7.26M – 7441
2016
Q1 		$7.26M Sell
85,500
-393,600
-82% -$29.3M ﹤0.01% 2462
2015
Q4 		$37.8M Buy
479,100
+298,200
+165% +$23.5M 0.01% 1321
2015
Q3 		$12.7M Buy
+180,900
New +$14.9M ﹤0.01% 2056
2015
Q1 		– Sell
-58,100
Closed -$5.84M – 7438
2014
Q4 		$5.84M Buy
58,100
+26,900
+86% +$2.68M ﹤0.01% 2849
2014
Q3 		$3M Sell
31,200
-23,100
-43% -$2.19M ﹤0.01% 3527
2014
Q2 		$5.06M Hold
54,300
– – ﹤0.01% 3021
2014
Q1 		$4.51M Sell
54,300
-176,200
-76% -$14.3M ﹤0.01% 3149
2013
Q4 		$19.3M Buy
230,500
+222,900
+2,933% +$18.2M 0.01% 1773
2013
Q3 		$564K Sell
7,600
-362,300
-98% -$27.2M ﹤0.01% 5080
2013
Q2 		$29.3M Buy
+369,900
New +$29.7M 0.01% 1246

Other funds holding MJN

PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
FNBOO
First National Bank of Omaha Omaha, Nebraska $3.55B AUM 27.24% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Goldman Sachs's MJN Position: Q2 2017 in Review

Goldman Sachs sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 3,696,172 shares — an estimated $329M sold.

Goldman Sachs first reported a position in MJN in Q2 2013 and held it in 16 quarters. The position peaked at $530M in Q4 2015. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Goldman Sachs reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Goldman Sachs sold 3,696,172 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $329M.
  • Goldman Sachs first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 16 quarters.
  • Goldman Sachs's Mead Johnson Nutrition Company position peaked at $530M in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Goldman Sachs's 13F filing for Q2 2017, filed 14 Aug 2017.